Mesenchymal stem cells for the treatment of cerebral palsy
Cerebral palsy is a lifelong disorder characterized by movement disorders and postural problems caused by non-progressive brain injuries. Although there is no cure, mesenchymal stem cell (MSC) therapies offer hope for treatment options to repair the central nervous system.
Studies show that MSCs can improve the damaged environment through paracrine mechanisms. Recent clinical studies confirm the safety and potential of human umbilical cord-derived MSCs (UC-MSCs) to improve motor function in children with cerebral palsy.
In summary, mesenchymal stem cell therapy can improve patients' functional performance, although individual responses vary. Children with high levels of disability benefit, but less than children with lower levels of disability. Younger patients respond better, but older children also show improvements.
Early intervention in high-risk children is crucial for optimal outcomes. This underlines the need to further develop MSC interventions as first-line treatment, as current standard treatments are not sufficiently effective.
"Complication in mother or child", commentary by Prof. Breymman (NZZ readers' letter)
Letter to the editor - Prof. Breymann of 27.10.25 in response to the article "Child's death in the birth center in court", NZZ / Andreas Leisi, 22.10.25). As an obstetrician, I have been attending births for thirty years, both vaginal births and those by caesarean section. From the daigram of the Health Directorate of the...
Care during the menopause: New consultation with Prof. Christian Breymann in Lausanne
Consultation hours at the AMiiA clinic in Lausanne From June 20, 2025, Prof. Christoph Breymann, MD, will be offering specialized consultation hours at the AMiiA clinic in Lausanne. You are in the middle of life - and want to be well accompanied through the menopause...